Ten-Year Results of Accelerated Partial-Breast Irradiation with Interstitial Multicatheter Brachytherapy after Breast-Conserving Surgery for Low-Risk Early Breast Cancer-Reference-Cited by-同舟云学术

Ten-Year Results of Accelerated Partial-Breast Irradiation with Interstitial Multicatheter Brachytherapy after Breast-Conserving Surgery for Low-Risk Early Breast Cancer

Published:2024-03-13 Issue:6 Volume:16 Page:1138
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Rodríguez-Ibarria Nieves G.¹,Pinar Beatriz¹²^ORCID,García Laura¹,Cabezón Auxiliadora¹,Rey-Baltar Dolores¹,Rodríguez-Melcón Juan Ignacio¹,Lloret Marta¹²,Lara Pedro C.³⁴^ORCID

Affiliation:

1. Radiation Oncology Department, Dr. Negrin University Hospital Las Palmas GC, 35010 Las Palmas de Gran Canaria, Spain

2. Medical School, Las Palmas University, 35001 Las Palmas de Gran Canaria, Spain

3. Oncology Department, Canarian Comprehensive Cancer Center, Fernando Pessoa Canarias University, 35001 Las Palmas de Gran Canaria, Spain

4. Canarian Insitute for Cancer Research, 380204 San Cristobal de La Laguna, Spain

Abstract

Patients with an early carcinoma of the breast are commonly treated by breast-conserving surgery (BCS) and postoperative radiotherapy. Partial-breast irradiation has gained acceptance in the last few years. Between December 2008 and December 2017, 182 low-risk breast cancer patients treated by BCS in the four university hospitals of the province of Las Palmas and treated with APBI using interstitial multicatheter brachytherapy were included in this study. After a mean follow-up for survivors of 10 years, the treatment was shown to be safe, as no severe acute/late toxicity (grade ≥ 3) was observed. The 10-year IBTR was 1.7% (95%CI: 0.7–2.7%), and the cause-specific survival was 94.9% (95%CI: 93.2–96.6%). We suggest that multicatheter brachytherapy after BCS is safe and effective in early breast cancer patients.

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/6/1138/pdf

Reference22 articles.

1. Early Breast Cancer Trialists Collaborative Group (EBCTCG) (2011). Effects of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet, 378, 1707–1716.

2. START Trialists’ Group, Bentzen, S.M., Agrawal, R.K., Aird, E.G., Barrett, J.M., Barrett-Lee, P.J., Dobbs, H.J., Hopwood, P., Lawton, P.A., and Magee, B.J. (2008). The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol., 9, 331–341.

3. START Trialists’ Group, Bentzen, S.M., Agrawal, R.K., Aird, E.G., Barrett, J.M., Barrett-Lee, P.J., Bentzen, S.M., Bliss, J.M., Brown, J., and Dewar, J.A. (2008). The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomized trial. Lancet, 371, 1098–1107.

4. Long-term results of hypofractionated radiation therapy for breast cancer;Whelan;N. Engl. J. Med.,2010

5. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicenter, non-inferiority, randomized, phase 3 trial;Brunt;Lancet,2020